In previous work, our group has demonstrated that B cells from SN in patients with cancer are activated and show clonal expansion specifically against the tumor [34], as well as that B cells in SN activate CD4+ T-cell-mediated anti-tumor responses. This evidence concerns the gene CD4 and neoplasm.